Sequent Medical Inc. and Inceptus Medical Announce a Licensing Agreement on MicroBraid Technology
Published: Mar 28, 2012
ALISO VIEJO, Calif., March 28, 2012 /PRNewswire/ -- Sequent Medical, Inc. and Inceptus Medical, LLC announced today an agreement that provides Inceptus Medical with a license to Sequent Medical's MicroBraid technology for use in select medical device applications. Sequent Medical's WEB® Aneurysm Embolization System utilizes MicroBraid technology in the treatment of cerebral aneurysms. This agreement allows Inceptus Medical to also utilize MicroBraid technology for several new product opportunities where the proprietary technology may offer significant clinical advantages.
"Inceptus Medical plans to apply MicroBraid technology to cardiovascular applications for which the fine pore structure of this unique technology may offer clinical benefits in occlusion and healing," says Bob Rosenbluth, President of Inceptus Medical. Tom Wilder, President and CEO of Sequent Medical added, "As Sequent Medical continues to expand its neurovascular product offerings using MicroBraid technology, this agreement will allow the benefits of this technology to be extended to other patient populations."
About Sequent Medical, Inc.
Sequent Medical, Inc. is a neurovascular device company that is dedicated to the development of innovative catheter-based technologies for neurovascular specialists and their patients. The company developed proprietary MicroBraid technology to create the WEBAneurysm Embolization Device, a low porosity intrasaccular device that is deployed within a brain aneurysm to facilitate occlusion and healing. The WEB bears the CE Mark, and is available at select centers in Europe and other countries, but is not available for use in the United States. Sequent Medical, Inc. is headquartered in Aliso Viejo, California, and has a European operation based in Bonn, Germany. For more information, please visit www.sequentmedical.com.
About Inceptus Medical, LLC
Inceptus Medical is a medical device incubator with a mission to create and nurture innovative concepts into companies by providing a combination of experienced engineering, clinical research expertise, seasoned leadership and strong financial resources. Inceptus Medical was founded by serial entrepreneurs Bob Rosenbluth, Brian Cox, and Paul Lubock. The principals of Inceptus were also founders of several successful medical device startup companies including Microvention (now part of Terumo), Sequent Medical, and SenoRx (now part of CR Bard). Inceptus Medical recently completed financing for its initial operating company from Versant Ventures and U.S. Venture Partners. For more information, please visit www.inceptusmedical.com.
SOURCE Sequent Medical, Inc.; Inceptus Medical, LLC